• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人凝血酶调节蛋白中由表皮生长因子样结构组成的结构域对于凝血酶结合和蛋白C活化至关重要。

A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation.

作者信息

Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S

机构信息

Department of Laboratory Medicine, Mie University School of Medicine, Japan.

出版信息

J Biol Chem. 1989 Mar 25;264(9):4872-6.

PMID:2538465
Abstract

Thrombomodulin, an endothelial thrombin receptor, acts as a cofactor for the thrombin-catalyzed activation of anticoagulant protein C. The extracellular region of human thrombomodulin consists of three tentative domains, a NH2-terminal domain (D1), a domain involving six consecutive epidermal growth factor-like structures (D2), and an O-glycosylation-rich domain (D3). To identify the domain onto which thrombin binds, a series of recombinant proteins corresponding to the entire protein, D1, D2, D1 + D2, D1 + D2 + D3, and D2 + D3 were expressed in simian COS-1 cells. The proteins were partially purified by rabbit anti-thrombomodulin-F(ab')2-agarose chromatography. Western blotting analysis showed the expression of the respective recombinant proteins. All proteins involving D2, as well as D2 alone, had cofactor activity that allowed binding directly to thrombin, but D1 did not. The cofactor activity of the entire protein but not the mutants is increased in the presence of phospholipids and this is the only protein that binds to the phospholipid layer. These results indicate that the domain involving the epidermal growth factor-like structures of thrombomodulin is essential for thrombin binding and expression of the cofactor activity for protein C activation and that none of the extracellular domains interact with phospholipids.

摘要

血栓调节蛋白是一种内皮凝血酶受体,作为凝血酶催化的抗凝蛋白C活化的辅因子。人血栓调节蛋白的细胞外区域由三个暂定结构域组成,一个氨基末端结构域(D1)、一个包含六个连续表皮生长因子样结构的结构域(D2)和一个富含O-糖基化的结构域(D3)。为了确定凝血酶结合的结构域,在猴COS-1细胞中表达了一系列与完整蛋白、D1、D2、D1+D2、D1+D2+D3和D2+D3相对应的重组蛋白。通过兔抗血栓调节蛋白-F(ab')2-琼脂糖层析对这些蛋白进行了部分纯化。蛋白质印迹分析显示了各个重组蛋白的表达。所有包含D2的蛋白以及单独的D2都具有辅因子活性,能够直接与凝血酶结合,但D1没有。在磷脂存在的情况下,完整蛋白而非突变体的辅因子活性增加,并且这是唯一与磷脂层结合的蛋白。这些结果表明,血栓调节蛋白中包含表皮生长因子样结构的结构域对于凝血酶结合以及蛋白C活化的辅因子活性表达至关重要,并且细胞外结构域均不与磷脂相互作用。

相似文献

1
A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation.人凝血酶调节蛋白中由表皮生长因子样结构组成的结构域对于凝血酶结合和蛋白C活化至关重要。
J Biol Chem. 1989 Mar 25;264(9):4872-6.
2
Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Ca(2+)-mediated binding to protein C.人血栓调节蛋白第四表皮生长因子样结构中的天冬氨酸349在其钙介导的与蛋白C结合过程中发挥作用。
J Biol Chem. 1991 Oct 25;266(30):19886-9.
3
Further localization of binding sites for thrombin and protein C in human thrombomodulin.凝血酶和蛋白C在人血栓调节蛋白中结合位点的进一步定位
J Biol Chem. 1990 Nov 25;265(33):20156-9.
4
Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity.膜结合型人血栓调节蛋白的功能结构域。辅因子活性需要表皮生长因子样结构域4至6以及富含丝氨酸/苏氨酸的结构域。
J Biol Chem. 1992 Mar 25;267(9):6164-70.
5
Sequences required for thrombomodulin cofactor activity within the fourth epidermal growth factor-like domain of human thrombomodulin.人血栓调节蛋白第四表皮生长因子样结构域内血栓调节蛋白辅因子活性所需的序列。
J Biol Chem. 1993 Jul 15;268(20):15312-7.
6
The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity.人血栓调节蛋白的最后三个连续的表皮生长因子样结构构成了蛋白C激活辅因子活性和抗凝活性的最小功能域。
J Biol Chem. 1989 Jun 25;264(18):10351-3.
7
Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation.人血栓调节蛋白的结构与表达,一种内皮细胞上的凝血酶受体,作为蛋白C活化的辅因子。
EMBO J. 1987 Jul;6(7):1891-7. doi: 10.1002/j.1460-2075.1987.tb02448.x.
8
Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.凝血酶激活的纤溶抑制物的激活需要血栓调节蛋白的表皮生长因子样结构域3,并且被蛋白C竞争性抑制。
J Biol Chem. 1998 May 15;273(20):12135-9. doi: 10.1074/jbc.273.20.12135.
9
Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity.对人血栓调节蛋白表皮生长因子样结构域进行丙氨酸扫描诱变,确定了其辅因子活性的关键残基。
J Biol Chem. 1993 Feb 5;268(4):2888-92.
10
The role of complex formation and epidermal growth factor-like domains in the regulation of blood coagulation by the thrombomodulin-protein C system.凝血调节蛋白-蛋白C系统中复合物形成和表皮生长因子样结构域在血液凝固调节中的作用。
Nihon Ketsueki Gakkai Zasshi. 1989 Dec;52(8):1343-9.

引用本文的文献

1
Thrombomodulin: A key regulator of intravascular blood coagulation, fibrinolysis, and inflammation, and a treatment for disseminated intravascular coagulation.血栓调节蛋白:血管内血液凝固、纤维蛋白溶解和炎症的关键调节因子,也是治疗弥散性血管内凝血的一种药物。
Proc Jpn Acad Ser B Phys Biol Sci. 2025 Feb 10;101(2):75-97. doi: 10.2183/pjab.101.006. Epub 2024 Dec 18.
2
VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.VhH 抗血栓调节蛋白克隆 1 抑制 TAFI 在流动状态下的人全血中的活化,并增强纤溶。
J Thromb Haemost. 2022 May;20(5):1213-1222. doi: 10.1111/jth.15674. Epub 2022 Mar 11.
3
Rare Defects: Looking at the Dark Face of the Thrombosis.
罕见缺陷:审视血栓形成的黑暗面。
Int J Environ Res Public Health. 2021 Aug 30;18(17):9146. doi: 10.3390/ijerph18179146.
4
Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening.重组人可溶性血栓调节蛋白通过降低脂多糖诱导的内皮细胞僵硬来抑制单核细胞黏附。
Cells. 2020 Jul 30;9(8):1811. doi: 10.3390/cells9081811.
5
A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.一例因血栓调节蛋白突变导致凝血酶结合缺陷且蛋白C和凝血酶激活的纤维蛋白溶解抑制物(TAFI)未被激活的病例。
Blood Adv. 2020 Jun 23;4(12):2631-2639. doi: 10.1182/bloodadvances.2019001155.
6
Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant. 2017 Jul;52(7):1068-1070. doi: 10.1038/bmt.2017.65. Epub 2017 Apr 3.
7
Thrombomodulin distribution during murine development.血栓调节蛋白在小鼠发育过程中的分布。
Rouxs Arch Dev Biol. 1993 Aug;202(6):364-370. doi: 10.1007/BF00188735.
8
Novel technologies to engineer graft for tolerance induction.用于诱导耐受性的工程化移植物的新技术。
Curr Opin Organ Transplant. 2016 Feb;21(1):74-80. doi: 10.1097/MOT.0000000000000270.
9
The multiple roles of epidermal growth factor repeat O-glycans in animal development.表皮生长因子重复序列O-聚糖在动物发育中的多重作用。
Glycobiology. 2015 Oct;25(10):1027-42. doi: 10.1093/glycob/cwv052. Epub 2015 Jul 14.
10
Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation.血栓调节蛋白/活化蛋白 C 系统在脓毒症弥散性血管内凝血中的作用。
J Intensive Care. 2015 Jan 7;3(1):1. doi: 10.1186/s40560-014-0050-7. eCollection 2015.